Source Post

Adam May on $ABVX's blowout data and subsequent stock crash

The host Andrew Walker welcomes Adam May back to the Yet Another Value Podcast to discuss biotech investing, focusing on Abc (ABVX) and Nectar Therapeutics. The conversation highlights Abc's recent blowout data release, which was accompanied by safety concerns, leading to a significant stock price drop. Walker discloses a personal long position in Abc and Nectar.

Linked Mentions

Tickers discussed in this post

ABVXNeutralMedium ConvictionSignal-backedPrimary

Abc (ABVX) released blowout data but faced safety concerns, causing its stock to crash, making it an interesting situation for investors.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.